Objectives: To evaluate the efficacy and safety of green tea extract in the treatment of the patients with meibomian gland dysfunction and dry eye.
Design: Clinical Trial stage 2, Single Center, Randomized, double blinded, control with placebo.
Setting and conduct: We will select Sixty patients with dry eye that will divide 2 group. Age will range from 30 to 70 years. In the first group, we will use artificial tear eye drops and in second group artificial tears plus green tea extract. All Patients will evaluate at the beginning and end of the study (one month later) for signs of dry eye, tear production, tear film stability, ocular surface and Meibomian glands health.
Major incliusion criteria included: Dry eye and meibomian gland dysfunction.
Major exclusion criteria included: Use of ophthalmic medication in one month before study, ocular surface disorders such as corneal surface damage, eyelid complications and previous ocular surgery.
Intervention: In the first group, we will use artificial tear eye drops and in second group artificial tears plus green tea extract.
Main outcome measures (variables): Signs of dry eye, tear production, tear film stability, ocular surface and Meibomian glands health.